Lindenwold Advisors Johnson & Johnson Transaction History

Lindenwold Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$154.35 - $166.11 $164,845 - $177,405	-1,068 Reduced 12.78%	7,289 $1.21 Million
Q1 2023 May 05, 2023	BUY	$151.05 - $180.26 $17,823 - $21,270	118 Added 1.43%	8,357 $1.3 Million
Q4 2022 Feb 13, 2023	BUY	$160.2 - $179.79 $15,379 - $17,259	96 Added 1.18%	8,239 $1.46 Million
Q3 2022 Oct 28, 2022	SELL	$161.33 - $179.52 $6,614 - $7,360	-41 Reduced 0.5%	8,143 $1.33 Million
Q2 2022 Aug 05, 2022	BUY	$168.19 - $186.01 $23,714 - $26,227	141 Added 1.75%	8,184 $1.45 Million
Q1 2022 May 09, 2022	SELL	$158.14 - $179.59 $112,437 - $127,688	-711 Reduced 8.12%	8,043 $1.43 Million
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $1.37 Million - $1.51 Million	8,754 New	8,754 $1.5 Million

4,239

1.7B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $405B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Lindenwold Advisors, based on Form 13F filings with the SEC.

Stay updated on Lindenwold Advisors with notifications on news.